Clinical Study With Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol

Last updated: March 25, 2024
Sponsor: University of Pavia
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol

Clinical Study ID

NCT06340308
PARAF 986117570
  • Ages > 18
  • All Genders

Study Summary

To evaluate the effects of a nutraceutical containing Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol on lipid profile

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • LDL Cholesterol > 115 mg/dl and < 190 mg/dl
  • primary prevention

Exclusion

Exclusion Criteria:

  • patients with neoplastic and liver diseases, renal failure and diabetes mellitus
  • pregnant or breastfeeding women
  • hypersensitivity to any of the ingredients
  • therapy with lipid-lowering drugs

Study Design

Total Participants: 36
Treatment Group(s): 1
Primary Treatment: Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol
Phase:
Study Start date:
June 07, 2023
Estimated Completion Date:
May 31, 2024

Study Description

To evaluate the effects of a nutraceutical containing Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol compared to placebo on lipid profile in patients with LDL cholesterol > 115 and < 190 mg/dl.Patients were allocated to receive 1 or 2 tablets of the nutraceutical for 12 weeks.

Connect with a study center

  • IRCCS Policlinico S. Matteo Foundation

    Pavia, 27100
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.